Techno-economic analysis of a transient plant-based platform for monoclonal antibody production.

Nandi, Somen; Kwong, Aaron T; Holtz, Barry R; Erwin, Robert L; Marcel, Sylvain; McDonald, Karen A

Nandi, Somen; Kwong, Aaron T; Holtz, Barry R; Erwin, Robert L; Marcel, Sylvain; McDonald, Karen A.

Afiliação

Nandi S; a Global HealthShare® Initiative, Department of Molecular and Cellular Biology, University of California at Davis , Davis , CA , USA.
Kwong AT; a Global HealthShare® Initiative, Department of Molecular and Cellular Biology, University of California at Davis , Davis , CA , USA.
Holtz BR; b Department of Chemical Engineering , University of California at Davis , Davis , CA , USA.
Erwin RL; c iBio CMO LLC , Bryan , TX , USA.
Marcel S; c iBio CMO LLC , Bryan , TX , USA.
McDonald KA; c iBio CMO LLC , Bryan , TX , USA.

MAbs ; 8(8): 1456-1466, 2016.

Article em En | MEDLINE | ID: mdl-27559626

Assuntos

Anticorpos Monoclonais/biossíntese; Reatores Biológicos; Biotecnologia/métodos; Nicotiana; Plantas Geneticamente Modificadas; Anticorpos Monoclonais/economia; Reatores Biológicos/economia; Biotecnologia/economia; Humanos

Palavras-chave

Monoclonal antibodies; plant-made pharmaceuticals; techno-economic analysis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nicotiana / Biotecnologia / Plantas Geneticamente Modificadas / Reatores Biológicos / Anticorpos Monoclonais Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google